Patents Assigned to Structural Genomix, Inc.
  • Publication number: 20060035898
    Abstract: The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 16, 2006
    Applicant: Structural GenomiX, Inc.
    Inventors: William Arnold, Andreas Gosberg, Zhe Li, Ruo Steensma, Mark Wilson
  • Patent number: 6656267
    Abstract: A crystallization tray includes a plurality of crystallization cells, each cell having a reservoir adapted to receive an equilibrating solution, a shelf located adjacent to the reservoir and adapted for use as a temporary cryogenic holding area for a crystallized substance and/or a sample holding area, and a sample drop receptacle carried by the shelf and adapted to receive a sample drop including a crystallizable substance. A related method for forming macromolecular crystals includes dispensing an equilibrating solution in the reservoirs, dispensing a plurality of macromolecular solution droplets in the sample drop receptacles, covering the cells with a cover; and crystallizing the crystallizable substance by vapor diffusion.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: December 2, 2003
    Assignee: Structural Genomix, Inc.
    Inventor: Janet Newman
  • Publication number: 20030158671
    Abstract: A system and method for predicting the active site residues in a target protein. The target protein, referred to interchangeably as the-target amino sequence or the target sequence, is pairwise aligned with a set of query sequences. Using these multiple pairwise sequence alignments, residue positions within the target sequence which satisfy specified sequence-based criteria are identified as candidate active site positions. Candidate active site positions are mapped to a three-dimensional representation of the target sequence and filtered against structure-based criteria. Positions within the target sequence that satisfy both the sequence-based and structure-based criteria are predicted to be active site residues.
    Type: Application
    Filed: July 15, 2002
    Publication date: August 21, 2003
    Applicant: Structural Genomix, Inc.
    Inventor: Ketan S. Gajiwala
  • Publication number: 20030010278
    Abstract: A crystallization tray includes a plurality of crystallization cells, each cell having a reservoir adapted to receive an equilibrating solution, a shelf located adjacent to the reservoir and adapted for use as a temporary cryogenic holding area for a crystallized substance and/or a sample holding area, and a sample drop receptacle carried by the shelf and adapted to receive a sample drop including a crystallizable substance. A related method for forming macromolecular crystals includes dispensing an equilibrating solution in the reservoirs, dispensing a plurality of macromolecular solution droplets in the sample drop receptacles, covering the cells with a cover; and crystallizing the crystallizable substance by vapor diffusion.
    Type: Application
    Filed: July 10, 2001
    Publication date: January 16, 2003
    Applicant: Structural GenomiX, Inc.
    Inventor: Janet Newman
  • Patent number: 6503320
    Abstract: A blocking device for remote, selective blocking of a cold stream used in a protein crystal annealing process during X-ray protein crystallography includes a blocking member adapted to be selectively moved between at least a blocking position where the blocking member blocks the cold stream and a non-blocking position where the blocking member does not block the cold stream, and an actuation mechanism adapted to impart movement to the blocking member to cause the blocking member to be selectively moved between at least the blocking position and the non-blocking position.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: January 7, 2003
    Assignee: Structural Genomix, Inc.
    Inventors: Janet Newman, Jon A. Christopher, Brian L. Ganz, James A. Benjamin